Trolox
Based on 36 publication(s) in Google Scholar
Trolox is an analogue of vitamin E with a powerful antioxidant effect. Trolox is also a powerful inhibitor of membrane damage.
For research use only. We do not sell to patients.
- Purity: 99.90%
- CAS No.: 53188-07-1
- Formula: C14H18O4
- Molecular Weight:250.29
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
Publications Citing Use of MedChemExpress (MCE) Trolox
More- Nature. 2025 May;641(8061):202-210. [Abstract]
- Nature. 2024 Jul;631(8021):654-662. [Abstract]
- Nat Commun. 2023 Apr 22;14(1):2320. [Abstract]
- Adv Sci (Weinh). 2025 Aug 7:e09208. [Abstract]
- Adv Sci (Weinh). 2024 Aug;11(31):e2308307. [Abstract]
- J Nanobiotechnology. 2025 Mar 29;23(1):258. [Abstract]
- Int J Biol Sci. 2023 Feb 27;19(5):1471-1489. [Abstract]
- Food Chem. 2026 Mar 28:515:149066. [Abstract]
- Cell Death Dis. 2021 Apr 1;12(4):338. [Abstract]
- Proc Natl Acad Sci U S A. 2024 Oct 22;121(43):e2407579121. [Abstract]
- EMBO J. 2023 Jan 16;42(2):e111268. [Abstract]
- Cell Death Discov. 2025 Oct 6;11(1):430. [Abstract]
- Cell Death Discov. 2022 May 2;8(1):238. [Abstract]
- Cell Rep. 2022 Oct 11;41(2):111462. [Abstract]
- Cell Rep. 2022 Sep 20;40(12):111381. [Abstract]
- Cell Biosci. 2023 May 13;13(1):87. [Abstract]
- Microchem J. 2026 Feb 9.
- Int J Mol Sci. 2025 Aug 23;26(17):8201. [Abstract]
- PLoS Pathog. 2025 Apr 8;21(4):e1013060. [Abstract]
- Cancers (Basel). 2025 Dec 27;18(1):92. [Abstract]
- Nanomaterials. 2026 Mar 27;16(7):405. [Abstract]
- ACS Omega. 2025 Aug 21;10(34):39192-39202. [Abstract]
- Exp Gerontol. 2024 May:189:112401. [Abstract]
- Transl Oncol. 2024 Jun:44:101938. [Abstract]
- Nanotoxicology. 2022 Nov-Dec;16(9-10):829-843. [Abstract]
- Neurotox Res. 2020 Dec;38(4):859-870. [Abstract]
- Life Sci Alliance. 2022 Nov 1;6(1):e202201667. [Abstract]
- Fitoterapia. 2024 Jun:175:105908. [Abstract]
- bioRxiv. 2026 May 21.
- Res Sq. 2026 Jan 9.
- Res Sq. 2025 Feb 16.
- Sri Lanka Journal of Indigenous Medicine. 2024; 09(01): 820-824
- Med Rev (2021). 2024 Jun 14;4(6):531-543. [Abstract]
- bioRxiv. 2023 Dec 5.
- bioRxiv. 2023 Dec 20.
- Oxid Med Cell Longev. 2020 Jan 27;2020:5829521. [Abstract]
-
Cell Proliferation/Viability Assay
-
Bio/Physico-chemical Assay
-
Flow Cytometry
-
WB
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
| Erythrocyte | IC50 |
101 μM
Compound: trolox
|
Antioxidant activity assessed as inhibition of AAPH-induced hemolysis in rat RBC after 3 hrs
Antioxidant activity assessed as inhibition of AAPH-induced hemolysis in rat RBC after 3 hrs
|
[PMID: 12828473] |
| HBL-100 | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
| HeLa | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
| HepG2 | IC50 |
>300 μM
Compound: TroH
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27344490] |
| HL-60 | IC50 |
0.3 μg/mL
Compound: Trolox
|
Antioxidant activity in PMA-stimulated Homo sapiens (human) HL60 cells assessed as inhibition of intracellular ROS generation incubated for 30 min prior to PMA stimulation measured after 30 min by DCFH-DA assay
Antioxidant activity in PMA-stimulated Homo sapiens (human) HL60 cells assessed as inhibition of intracellular ROS generation incubated for 30 min prior to PMA stimulation measured after 30 min by DCFH-DA assay
|
10.1007/s00044-011-9882-z |
| HL-60 | IC50 |
1.4 μM
Compound: Trolox
|
Inhibition of PMA induced ROS generation in human HL60 cells assessed as inhibition of ROA mediated oxidation of DCFH
Inhibition of PMA induced ROS generation in human HL60 cells assessed as inhibition of ROA mediated oxidation of DCFH
|
[PMID: 23547843] |
| HL-60 | IC50 |
3.6 μM
Compound: trolox
|
Antioxidant activity in human HL60 cells assessed as inhibition of TPA-stimulated hydrogen peroxide induced DCFH-DA oxidation by fluorometric microplate assay
Antioxidant activity in human HL60 cells assessed as inhibition of TPA-stimulated hydrogen peroxide induced DCFH-DA oxidation by fluorometric microplate assay
|
[PMID: 16562834] |
| MCF7 | IC50 |
>300 μM
Compound: TroH
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27344490] |
| MCF7 | IC50 |
1461 μM
Compound: 14
|
Compound was tested for antiproliferative activity against human breast cancer cell line MCF-7 in MTT assay
Compound was tested for antiproliferative activity against human breast cancer cell line MCF-7 in MTT assay
|
[PMID: 9873556] |
| Melan-a | IC50 |
>300 μM
Compound: 2
|
Depigmentation activity in mouse Melan-a cells assessed as inhibition of melanin formation after 4 days
Depigmentation activity in mouse Melan-a cells assessed as inhibition of melanin formation after 4 days
|
[PMID: 22071299] |
| Melan-a | IC50 |
300 μM
Compound: 2
|
Cytotoxicity against mouse Melan-a cells by modified crystal voilet assay
Cytotoxicity against mouse Melan-a cells by modified crystal voilet assay
|
[PMID: 22071299] |
| MT4 | IC50 |
200 μM
Compound: TroH
|
Cytotoxicity against human MT4 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MT4 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27344490] |
| NRK-52E | EC50 |
1.9 μM
Compound: Trolox
|
Cytoprotective activity against LPS-induced NRK-52E cells assessed as reduction in cell death measured every 5 min for 72 hrs by xCELLigence based RTCA analysis
Cytoprotective activity against LPS-induced NRK-52E cells assessed as reduction in cell death measured every 5 min for 72 hrs by xCELLigence based RTCA analysis
|
[PMID: 32141747] |
| PC-12 | IC50 |
20 μM
Compound: Trolox
|
Antioxidant activity in rat PC12 cells assessed as inhibition of Fe2+-induced ROS production after 1 hr by DCFH-DA staining-based fluorometric analysis
Antioxidant activity in rat PC12 cells assessed as inhibition of Fe2+-induced ROS production after 1 hr by DCFH-DA staining-based fluorometric analysis
|
[PMID: 23751098] |
| PC-12 | IC50 |
20 μM
Compound: Trolox
|
Antioxidant activity in rat PC12 cells assessed as inhibition of Fe2+-induced reactive oxygen species formation after 1 hr by DCFH-DA dye-based fluorometric analysis
Antioxidant activity in rat PC12 cells assessed as inhibition of Fe2+-induced reactive oxygen species formation after 1 hr by DCFH-DA dye-based fluorometric analysis
|
[PMID: 26447940] |
| RAW264.7 | IC50 |
30 μM
Compound: Trx
|
Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced ROS production measured after 4 hrs by H2DCFDA-AM probe based fluorescence assay
Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced ROS production measured after 4 hrs by H2DCFDA-AM probe based fluorescence assay
|
[PMID: 29275229] |
| RPMI-8226 | IC50 |
>300 μM
Compound: TroH
|
Cytotoxicity against human RPMI8226 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human RPMI8226 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27344490] |
| SH-SY5Y | IC50 |
49.55 μM
Compound: Trolox
|
Antioxidant activity against tert-butyl hydroperoxide-induced ROS evoked cell death in human SH-SY5Y cells
Antioxidant activity against tert-butyl hydroperoxide-induced ROS evoked cell death in human SH-SY5Y cells
|
[PMID: 18605718] |
| SH-SY5Y | IC50 |
82.3 μM
Compound: Trolox
|
Antioxidant activity in human SH-SY5Y cells assessed as inhibition of H2O2-induced DCFH oxidation measured after 1 hr by DCFH-DA dye based fluorescence assay
Antioxidant activity in human SH-SY5Y cells assessed as inhibition of H2O2-induced DCFH oxidation measured after 1 hr by DCFH-DA dye based fluorescence assay
|
[PMID: 27541262] |
| SW1573 | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
| T47D | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
| U-937 | IC50 |
300 μM
Compound: TroH
|
Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27344490] |
| WiDr | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
Trolox has shown to protect mammalian cells from oxidative damage. Trolox is effective in preventing myocyte necrosis in cell culture studies and in a canine model of two hours of left anterior descending coronary artery (LAD) occlusion followed by four hours of reperfusion[1].
Trolox could prevent oxidative stress-induced apoptosis in thymocytes. Pre- or post-treatment of cells with Trolox reduced H2O2-induced DNA fragmentation to control levels and below. [2].
Trolox is a hydrophilic analog of alpha-tocopherol and reported to scavenge peroxyl radicals better than vitamin E in sodium dodecyl sulfate micelles and in liposomes. Trolox prolongs substantially the survival of human ventricular myocytes and hepatocyte against oxyradicals generated with xanthine oxidase plus hypoxanthine, and prevented lysis of red cells exposed to an azo-initiator[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 53188-07-1
-
Appearance Solid
-
Molecular Weight 250.29
-
Formula C14H18O4
-
Color Off-white to gray
-
SMILES
O=C(C1(C)CCC2=C(C)C(O)=C(C)C(C)=C2O1)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 1 year -20°C 6 months
Publications (36)
-
Journal Impact Factor
-
Most Recent
-
Nature
2025 May;641(8061):202-210. PMID: 40140567 -
Nature
2024 Jul;631(8021):654-662. PMID: 38987590 -
Nat Commun
Observation of structural switch in nascent SAM-VI riboswitch during transcription at single-nucleotide and single-molecule resolution. [Abstract]2023 Apr 22;14(1):2320. PMID: 37087479 -
Adv Sci (Weinh)
2025 Aug 7:e09208. PMID: 40776529
Trolox purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Aug 7:e09208. [Abstract]
Trolox (100 µM), a hydrophilic analogue of VE with potent antioxidant effect, was used as a control of VE. After a short incubation time of 6 h, cathepsin inhibitors (CA‐074, Pep‐A, and E‐64), Ca2+ chelator, and cellular ROS scavengers (NAC, VC, and Trolox) displayed a delayed effect of ipLNP cytotoxicity.
-
Adv Sci (Weinh)
Aloperine Suppresses Cancer Progression by Interacting with VPS4A to Inhibit Autophagosome-lysosome Fusion in NSCLC. [Abstract]2024 Aug;11(31):e2308307. PMID: 39166458 -
J Nanobiotechnology
Single-cell multi-omics analysis reveals the mechanism of action of a novel antioxidant polyphenol nanoparticle loaded with STAT3 agonist in mediating cardiomyocyte ferroptosis to ameliorate age-related heart failure. [Abstract]2025 Mar 29;23(1):258. PMID: 40158134 -
Int J Biol Sci
Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. [Abstract]2023 Feb 27;19(5):1471-1489. PMID: 37056925 -
Food Chem
Optimization of multi-enzyme coupled debittering process: Effect on bitterness and bioactive components of Shatianyu (Citrus grandis L. Osbeck) whole fruit powder. [Abstract]2026 Mar 28:515:149066. PMID: 41990492 -
Cell Death Dis
2021 Apr 1;12(4):338. PMID: 33795638 -
Proc Natl Acad Sci U S A
Divergent molecular assembly and catalytic mechanisms between bacterial and archaeal RNase P in pre-tRNA cleavage. [Abstract]2024 Oct 22;121(43):e2407579121. PMID: 39413135 -
EMBO J
2023 Jan 16;42(2):e111268. PMID: 36408830 -
Cell Death Discov
Metabolic interplay between exogenous cystine and glutamine dependence in triple-negative breast cancer. [Abstract]2025 Oct 6;11(1):430. PMID: 41053011
Trolox purchased from MedChemExpress. Usage Cited in: Cell Death Discov. 2025 Oct 6;11(1):430. [Abstract]
Trolox (5 µM) also rescued TNBC cells from cystine deprivation-induced cell death by reducing ROS levels. Representative images of Hs578Ts(i)8 and SUM159 cells treated with Trolox and/or glutamine deprivation under cystine-deprived conditions.
-
Cell Death Discov
A novel SRSF3 inhibitor, SFI003, exerts anticancer activity against colorectal cancer by modulating the SRSF3/DHCR24/ROS axis. [Abstract]2022 May 2;8(1):238. PMID: 35501301 -
Cell Rep
2022 Oct 11;41(2):111462. PMID: 36223740
Trolox purchased from MedChemExpress. Usage Cited in: Cell Rep. 2022 Oct 11;41(2):111462. [Abstract]
With an alternative ROS scavenger, the vitamin E analog Trolox, Olaparib-induced ROS production was similarly suppressed
-
Cell Rep
Early-life vitamin B12 orchestrates lipid peroxidation to ensure reproductive success via SBP-1/SREBP1 in Caenorhabditis elegans. [Abstract]2022 Sep 20;40(12):111381. PMID: 36130518 -
Cell Biosci
Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth. [Abstract]2023 May 13;13(1):87. PMID: 37179385 -
-
Int J Mol Sci
2025 Aug 23;26(17):8201. PMID: 40943126 -
PLoS Pathog
Chlamydial protease-like activity factor targets SLC7A11 for degradation to induce ferroptosis and facilitate progeny releases. [Abstract]2025 Apr 8;21(4):e1013060. PMID: 40198689 -
Cancers (Basel)
Synthesis and Biological Evaluation of a Caffeic Acid Phenethyl Ester Derivatives as Anti-Hepatocellular Carcinoma Agents via Inhibition of Mitochondrial Respiration and Disruption of Cellular Metabolism. [Abstract]2025 Dec 27;18(1):92. PMID: 41514605 -
Nanomaterials
Effect of Fullerenol C60(OH)24 on Viability and Phagocytic Activity of Human Neutrophils. [Abstract]2026 Mar 27;16(7):405. PMID: 41972621 -
ACS Omega
2025 Aug 21;10(34):39192-39202. PMID: 40918390 -
Exp Gerontol
Endoplasmic reticulum stress-induced necroptosis promotes cochlear inflammation: Implications for age-related hearing loss. [Abstract]2024 May:189:112401. PMID: 38490286 -
Transl Oncol
Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer. [Abstract]2024 Jun:44:101938. PMID: 38492499 -
Nanotoxicology
Iron oxide nanoparticles cause surface coating- and core chemistry-dependent endothelial cell ferroptosis. [Abstract]2022 Nov-Dec;16(9-10):829-843. PMID: 36660964 -
Neurotox Res
2020 Dec;38(4):859-870. PMID: 32415528 -
Life Sci Alliance
Tanshinone functions as a coenzyme that confers gain of function of NQO1 to suppress ferroptosis. [Abstract]2022 Nov 1;6(1):e202201667. PMID: 36319062 -
Fitoterapia
New sesquiterpenoids with neuroprotective effects in vitro and in vivo from the Picrasma chinensis. [Abstract]2024 Jun:175:105908. PMID: 38479621 -
-
-
-
-
Med Rev (2021)
2024 Jun 14;4(6):531-543. PMID: 39664081 -
-
-
Oxid Med Cell Longev
2020 Jan 27;2020:5829521. PMID: 32089773
Trolox purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2020 Jan 27;2020:5829521. [Abstract]
The effects of Trolox on the expression of Nrf2 and its downstream targets. MDBK cells in 60 mm dishes pretreated with Trolox (1 mM) or DMSO control for 1 h are exposed to tBHP in the presence of Trolox or DMSO control for 2 h; the cell lysates are prepared for Western blots to detect the expression of Nrf2 and HO-1.
Solvent & Solubility
DMSO : 175 mg/mL (699.19 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : < 0.1 mg/mL (insoluble)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (8.31 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (8.31 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocol
Thymocytes are treated with Trolox (10 mM) before, during, or after 10 min exposure to 10 μM H2O2. Trolox incubations that are conducted before or after H2O2 exposures are performed in TCM. Trolox treatments that are administered concurrently with H2O2 are performed in PBS with ferrous sulfate[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Mickle DA, et al. Myocardial salvage with trolox and ascorbic acid for an acute evolving infarction. Ann Thorac Surg. 1989 Apr;47(4):553-7. [Content Brief]
[2]. Forrest VJ, et al. Oxidative stress-induced apoptosis prevented by Trolox. Free Radic Biol Med. 1994 Jun;16(6):675-84. [Content Brief]
[3]. Wu TW, et al. The cytoprotective effect of Trolox demonstrated with three types of human cells. Biochem Cell Biol. 1990 Oct;68(10):1189-94. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.9954 mL | 19.9768 mL | 39.9537 mL | 99.8841 mL |
| 5 mM | 0.7991 mL | 3.9954 mL | 7.9907 mL | 19.9768 mL | |
| 10 mM | 0.3995 mL | 1.9977 mL | 3.9954 mL | 9.9884 mL | |
| 15 mM | 0.2664 mL | 1.3318 mL | 2.6636 mL | 6.6589 mL | |
| 20 mM | 0.1998 mL | 0.9988 mL | 1.9977 mL | 4.9942 mL | |
| 25 mM | 0.1598 mL | 0.7991 mL | 1.5981 mL | 3.9954 mL | |
| 30 mM | 0.1332 mL | 0.6659 mL | 1.3318 mL | 3.3295 mL | |
| 40 mM | 0.0999 mL | 0.4994 mL | 0.9988 mL | 2.4971 mL | |
| 50 mM | 0.0799 mL | 0.3995 mL | 0.7991 mL | 1.9977 mL | |
| 60 mM | 0.0666 mL | 0.3329 mL | 0.6659 mL | 1.6647 mL | |
| 80 mM | 0.0499 mL | 0.2497 mL | 0.4994 mL | 1.2486 mL | |
| 100 mM | 0.0400 mL | 0.1998 mL | 0.3995 mL | 0.9988 mL |